Dimensional Fund Advisors
KBIO

Dimensional Fund Advisors’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-707
Closed -$10K – 3550
2014
Q4 		$10K Hold
707
– – ﹤0.01% 3460
2014
Q3 		$9K Hold
707
– – ﹤0.01% 3490
2014
Q2 		$13K Buy
+707
New +$12.1K ﹤0.01% 3525

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dimensional Fund Advisors's KBIO Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 707 shares — an estimated $10K sold.

Dimensional Fund Advisors first reported a position in KBIO in Q2 2014 and held it in 3 quarters. The position peaked at $13K in Q2 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 707 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $10K.
  • Dimensional Fund Advisors first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 3 quarters.
  • Dimensional Fund Advisors's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $13K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.